Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming Group N.V (PHAR) Long-Term Deferred Tax: 2019-2025

Historic Long-Term Deferred Tax for Pharming Group N.V (PHAR) over the last 5 years, with Sep 2025 value amounting to $27.5 million.

  • Pharming Group N.V's Long-Term Deferred Tax fell 25.21% to $27.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.5 million, marking a year-over-year decrease of 25.21%. This contributed to the annual value of $30.5 million for FY2024, which is 2.63% up from last year.
  • According to the latest figures from Q3 2025, Pharming Group N.V's Long-Term Deferred Tax is $27.5 million, which was down 11.91% from $31.2 million recorded in Q2 2025.
  • In the past 5 years, Pharming Group N.V's Long-Term Deferred Tax registered a high of $39.0 million during Q2 2024, and its lowest value of $21,187 during Q3 2022.
  • Moreover, its 3-year median value for Long-Term Deferred Tax was $29.8 million (2023), whereas its average is $30.2 million.
  • In the last 5 years, Pharming Group N.V's Long-Term Deferred Tax plummeted by 99.90% in 2022 and then spiked by 125,486.44% in 2023.
  • Over the past 5 years, Pharming Group N.V's Long-Term Deferred Tax (Quarterly) stood at $21.2 million in 2021, then climbed by 8.28% to $23.0 million in 2022, then increased by 29.55% to $29.8 million in 2023, then climbed by 2.63% to $30.5 million in 2024, then fell by 25.21% to $27.5 million in 2025.
  • Its Long-Term Deferred Tax was $27.5 million in Q3 2025, compared to $31.2 million in Q2 2025 and $18.4 million in Q1 2025.